What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing pet ownership.

What are the key drivers of the Pets External Parasiticide market?

Key drivers include rising demand for effective parasite control and growing awareness of animal health.

What are the major challenges facing the Pets External Parasiticide market?

Challenges include increasing resistance to parasiticides and regulatory constraints on product development.

Which regions are expected to lead the Pets External Parasiticide market?

North America and Europe are expected to dominate the market, driven by high pet ownership rates.

Who are the top companies in the Pets External Parasiticide market?

Major players include Merck, Bayer, and Eli Lilly, which offer a range of parasiticides.

What future opportunities exist in the Pets External Parasiticide market?

Future opportunities include the development of novel parasiticides and expanding into emerging markets.

How will technology impact the Pets External Parasiticide market?

Technology will drive innovation in product development and distribution, enhancing the future outlook.

What is the current regulatory landscape for the Pets External Parasiticide market?

The regulatory landscape is characterized by strict guidelines on product safety and efficacy.

How will the Pets External Parasiticide market evolve in the next 5 years?

The market will evolve through increasing adoption of digital technologies and growing demand for sustainable products.

Pets External Parasiticide Market Metrics & Forecast Analysis 2033

Pets External Parasiticide by Application (Dogs, Cats, Other), by Types (Injection, Unguent), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Pets External Parasiticide Market Size | CAGR 7.2 Forecast 2033

Pets External Parasiticide Market Metrics & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Pets External Parasiticide Market Overview

The Pets External Parasiticide market refers to the industry that provides products and services to prevent and treat external parasites in pets. As the global pet population continues to grow, the Pets External Parasiticide market size is expected to witness significant growth outlook, with a substantial market forecast and industry expansion anticipated over the forecast period. The scope of this market encompasses a range of products, including topical treatments, medicated shampoos, and oral medications, that are used to control and eliminate external parasites such as fleas, ticks, and mites. According to recent estimates, the current Pets External Parasiticide market size is approximately $4.5 billion, with a growth forecast of 7.3% CAGR from 2026 to 2033, driven by macro drivers such as increasing pet ownership, rising awareness of parasite-borne diseases, and advancements in parasiticide technology.

Loading chart…

Key forces shaping the Pets External Parasiticide industry include technology shifts towards more effective and convenient products, regulations governing the use of parasiticides, and consumer behavior driven by increasing awareness of pet health and wellness. The largest region for the Pets External Parasiticide market is North America, while the fastest-growing region is Asia-Pacific, driven by rising pet ownership and increasing awareness of parasite-borne diseases. Overall, the Pets External Parasiticide market is expected to experience significant growth and expansion over the forecast period, driven by a combination of demographic, technological, and regulatory factors.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boehringer Ingelheim; Zoetis; Merck; Elanco; Bayer; Virbac; Ceva Sante Animale; Vetoquinol; Bimeda Animal Health; Chanelle
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pets External Parasiticide market is poised for significant growth, driven by increasing pet ownership and rising awareness about animal health. The market dynamics are influenced by various factors, including technological advancements, regulatory frameworks, and shifting consumer preferences.

Growth Drivers2 items

The growing trend of pet humanization is driving the demand for effective and safe external parasiticides, contributing to the Pets External Parasiticide market size and growth forecast.

Advances in formulation technologies, such as spot-on treatments and collars, are enhancing the efficacy and convenience of external parasiticides, thereby fueling market growth.

Restraints2 items

Stringent regulatory requirements and the need for extensive testing and approval processes are limiting the entry of new players in the Pets External Parasiticide market and increasing the cost of product development.

Concerns about the environmental impact and toxicity of certain active ingredients used in external parasiticides are leading to increased scrutiny and potential restrictions on their use.

Opportunities2 items

The rising demand for natural and organic pet care products presents an opportunity for manufacturers to develop innovative, eco-friendly external parasiticides that appeal to pet owners seeking safer alternatives.

The growing pet population in emerging markets, particularly in Asia and Latin America, offers a significant opportunity for companies to expand their presence and tap into the increasing demand for external parasiticides.

Challenges2 items

The Pets External Parasiticide market is highly competitive, with established players competing on price, quality, and brand reputation, making it challenging for new entrants to gain market share.

The increasing prevalence of parasite resistance to certain active ingredients is a significant challenge, as it necessitates the development of new, effective treatments and formulation strategies.

Market Segmentation

Loading chart…

The Pets External Parasiticide market can be segmented based on Application, which refers to the specific use of external parasiticides on pets. This segmentation category contributes to the overall market size by highlighting the different ways in which external parasiticides are used to control and prevent parasitic infestations in pets. The application segment includes subtypes such as spot-on treatments, sprays, and shampoos, each with its own unique characteristics and market share.

Another key segmentation category in the Pets External Parasiticide market is Types, which refers to the different types of external parasiticides available in the market. This segmentation category contributes to the overall market size by providing insights into the various types of products available, including insecticides, acaricides, and repellents. Understanding the types of external parasiticides is crucial for Pets External Parasiticide segmentation, as it helps to identify market trends and opportunities.

Pets External Parasiticide Segmentation Breakdown7 items

Application

Dogs

Cats

Other

Types

Injection

Unguent

Regional Insights

Loading chart…

The Pets External Parasiticide market growth is anticipated to vary across regions, with the largest region being North America, accounting for approximately 35% of the global market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of pets, particularly in China and India, and rising awareness about pet health.

Key drivers for each region include: for North America, investments in research and development, demographics with a high percentage of pet owners, and a mature ecosystem with established players. For Europe, key drivers are policies supporting animal health, infrastructure with well-developed veterinary care, and adoption of premium pet care products. In Asia Pacific, drivers include demographics with a growing middle class, investments in pet care infrastructure, and rising awareness about pet health.

Latin America and Middle East & Africa are also expected to contribute to the regional forecast, with key drivers including adoption of pets, investments in animal health, and growing awareness about the importance of pet care. The Asia Pacific region is expected to drive the Pets External Parasiticide market growth, with a compound annual growth rate (CAGR) of 8%, followed by Latin America and Middle East & Africa.

Competitive Landscape

The Pets External Parasiticide market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Pets External Parasiticide competitive landscape is characterized by high competition, with key players employing various strategies to differentiate themselves. Global players such as Boehringer Ingelheim and Zoetis have a significant presence, while local companies focus on regional markets.

Companies in this market employ strategies such as M&A, partnerships, product launches, and R&D to stay competitive. Differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and commoditization. To mitigate these risks, companies focus on innovation, localization, and strategic partnerships. The following companies have notable strategies:

Boehringer Ingelheim: regional expansion

Zoetis: premium pricing

Merck: innovation pipeline

Elanco: vertical integration

Bayer: local manufacturing

Virbac: OEM tie-ups

Key Pets External Parasiticide Companies10 items

Boehringer Ingelheim

Zoetis

Merck

Elanco

Bayer

Virbac

Ceva Sante Animale

Vetoquinol

Bimeda Animal Health

Chanelle

Market Ecosystem

The Pets External Parasiticide ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream channels and end users. This ecosystem is characterized by a value chain that creates and captures value through the development, manufacturing, and distribution of external parasiticides for pets. The ecosystem boundaries are defined by the interactions between these participants, with value flowing from raw material suppliers to manufacturers, then to distributors, and ultimately to end users.

Raw material suppliers — provide active ingredients

OEMs / manufacturers — produce parasiticides

Distributors / channel partners — supply products to retailers

Regulators/standards bodies — establish product safety standards

Service providers / after-sales — offer guidance on product use

End users / buyers — purchase and apply parasiticides

Data/analytics providers — track product efficacy and sales

In the Pets External Parasiticide ecosystem, control points are primarily held by regulatory bodies and manufacturers, as they influence the adoption of products through compliance with safety standards and product development. Dependency risks arise from input constraints, such as the availability of active ingredients, and standards approvals, which can impact the production and distribution of parasiticides. Furthermore, the ecosystem's value chain analysis reveals that switching costs and partnerships between participants can affect the flow of value, while regional differences in regulations and market preferences can also shape the ecosystem's dynamics.

Recent Industry Insights

The Pets External Parasiticide industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Zoetis and PetDesk, have aimed to improve pet care services and enhance the distribution of parasiticides. Mergers and acquisitions, including the acquisition of Aratana Therapeutics by Elanco, have also been prominent. Furthermore, companies like Merck Animal Health have launched new products and technologies, such as topical treatments for flea and tick control. Regulatory changes, including updated guidelines from the FDA, have also impacted the industry. These developments reflect shifting consumer trends towards more convenient and effective parasiticide solutions, driving growth in the Pets External Parasiticide market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Pets External Parasiticide market outlook. The market exhibits moderate attractiveness, driven by increasing pet ownership and awareness about parasite control. The competitive landscape is characterized by high competitive intensity, with key players focusing on innovative product development and strategic partnerships. Over the long term, the market is expected to witness steady growth, driven by rising demand for effective and convenient parasiticide solutions.

The innovation landscape is evolving, with a focus on sustainable and environmentally friendly products. However, the market is not without risks, with key risk factors including regulatory changes, supply chain disruptions, and increasing competition. Despite these challenges, the demand-supply balance is expected to remain stable, with manufacturers adapting to changing market dynamics. Overall, the Pets External Parasiticide market presents opportunities for growth and innovation, driven by changing consumer preferences and advances in technology.

11 items

1. Executive Summary

2. Pets External Parasiticide Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pets External Parasiticide Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pets External Parasiticide Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Dogs

6.1.2. Cats

6.1.3. Other

6.2. Global Pets External Parasiticide Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Injection

6.2.2. Unguent

6.3. Global Pets External Parasiticide Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pets External Parasiticide Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pets External Parasiticide Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pets External Parasiticide Market Competition by Key Manufacturers

8.1. Global Pets External Parasiticide Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pets External Parasiticide: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boehringer Ingelheim

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zoetis

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Elanco

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bayer

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Virbac

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Ceva Sante Animale

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Vetoquinol

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bimeda Animal Health

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Chanelle

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pets External Parasiticide Market

Figure 4: Global Pets External Parasiticide Market: Drivers

Figure 5: Global Pets External Parasiticide Market: Challenges

Figure 6: Global Pets External Parasiticide Market: Trends

Figure 7: Global Pets External Parasiticide Market: Opportunity

Figure 8: Global Pets External Parasiticide Market: Restraint

Figure 9: Global Pets External Parasiticide Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pets External Parasiticide Market Value (USD Million) By Region

Figure 15: Global Pets External Parasiticide Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pets External Parasiticide Market Value (USD Million) By Region

Figure 23: Global Pets External Parasiticide Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Pets External Parasiticide Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pets External Parasiticide Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pets External Parasiticide Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pets External Parasiticide Market Value (USD Million) By Region

Table 10: Global Pets External Parasiticide Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pets External Parasiticide Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pets External Parasiticide Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pets External Parasiticide Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boehringer Ingelheim Basic Information And Sales Area

Table 31: Boehringer Ingelheim. Products Portfolio

Table 32: Zoetis Basic Information And Sales Area

Table 33: Zoetis. Products Portfolio

Table 34: Merck Basic Information And Sales Area

Table 35: Merck. Products Portfolio

Table 36: Elanco Basic Information And Sales Area

Table 37: Elanco. Products Portfolio

Table 38: Bayer Basic Information And Sales Area

Table 39: Bayer. Products Portfolio

Table 40: Virbac Basic Information And Sales Area

Table 41: Virbac. Products Portfolio

Table 42: Ceva Sante Animale Basic Information And Sales Area

Table 43: Ceva Sante Animale. Products Portfolio

Table 44: Vetoquinol Basic Information And Sales Area

Table 45: Vetoquinol. Products Portfolio

Table 46: Bimeda Animal Health Basic Information And Sales Area

Table 47: Bimeda Animal Health. Products Portfolio

Table 48: Chanelle Basic Information And Sales Area

Table 49: Chanelle. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Pets External Parasiticide Market Value (USD Million) By Region

Table 55: Global Pets External Parasiticide Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Pets External Parasiticide Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boehringer Ingelheim; Zoetis; Merck; Elanco; Bayer; Virbac; Ceva Sante Animale; Vetoquinol; Bimeda Animal Health; Chanelle
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options